Evaluation of the Correlations Between the Absorbed Bone Marrow Dose and Bone Marrow Response During the First Cycle of 177Lu-DOTATATE Treatment

被引：0
|
作者：
Hagmarker, L. [1 ]
Svensson, J. [2 ]
Ryden, T. [1 ]
Wangberg, B. [3 ]
Sundlov, A. [4 ]
Gleisner, K. Sjogreen [5 ]
Bernhardt, P. [1 ]
机构：
[1] Inst Clin Sci, Gothenburg, Sweden
[2] Dept Oncol, Gothenburg, Sweden
[3] Dept Surg, Gothenburg, Sweden
[4] Skane Univ Hosp, Dept Oncol, Lund, Sweden
[5] Lund Univ, Dept Radiat Phys, Lund, Sweden
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-433
引用
收藏
页码：S272 / S273
页数：2
相关论文
共 50 条
  • [31] Individualized absorbed doses to kidney and bone marrow in 200 patients undergoing therapy with 177Lu-octreotate
    Sandstrom, Mattias
    Garske, Ulrike
    Granberg, Dan
    Widstrom, Charles
    Eriksson, Barbro
    Sundin, Anders
    Lundqvist, Hans
    Lubberink, Mark
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [32] Clinical feasibility of Lu-177 EDTMP prescribed bone marrow irradiation dose concept in bone pain palliation
    Zaknun, John
    Bal, Chandrasekhar
    Saeed, Shabana
    Jameel, Ghazal
    Gaudiano, Javier
    Qureshy, Ahmad
    Traino, Claudio
    Mariani, Giuliano
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [33] ABSORBED DOSE TO BONE-MARROW IN TREATMENT OF POLYCYTHEMIA BY P-32
    SPIERS, FW
    BEDDOE, AH
    KING, SD
    HAYTER, CJ
    SMITH, AH
    BURKINSHAW, L
    ROBERTS, BE
    [J]. BRITISH JOURNAL OF RADIOLOGY, 1976, 49 (578): : 133 - 140
  • [34] Effect of time-varying radioactivity volume versus static volume in kidney absorbed dose estimates during 177Lu-DOTATATE therapy
    Sandstrom, M.
    Garske-Roman, U.
    Granberg, D.
    Sundin, A.
    Lubberink, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S421 - S421
  • [35] Prophylactic Peripheral Blood Stem Cell Collection in Patients with Extensive Bone-Marrow Infiltration of Neuroendocrine Tumours Prior to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE
    Sabet, Amir
    Mader, Nicolai
    Bittenbring, Joerg Thomas
    Khreish, Fadi
    Gruenwald, Frank
    Biersack, Hans Jurgen
    Ezziddin, Samer
    [J]. PHARMACEUTICALS, 2021, 14 (10)
  • [36] Individualized Dosimetry of Kidney and Bone Marrow in Patients Undergoing 177Lu-DOTA-Octreotate Treatment
    Sandstrom, Mattias
    Garske-Roman, Ulrike
    Granberg, Dan
    Johansson, Silvia
    Widstrom, Charles
    Eriksson, Barbro
    Sundin, Anders
    Lundqvist, Hans
    Lubberink, Mark
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (01) : 33 - 41
  • [37] Relevance of kidneys and bone marrow as dose-limiting organs during Lu-177-PSMA-DKFZ-617 therapy for patients with high bone tumor burden
    Gosewisch, A.
    Ilhan, H.
    Zach, C.
    Todica, A.
    Brosch, J.
    Vomacka, L.
    Bartenstein, P.
    Boening, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S111 - S111
  • [38] Evaluation of dose response after combined bone marrow and lesion based dosimetry
    Abuqbeitah, M.
    Demir, M.
    Yeyin, N.
    Kabasakal, L.
    Sonmezoglu, K.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S814 - S814
  • [39] Outpatient radioiodine therapy for thyroid cancer: The evaluation of urine activity, bone marrow absorbed dose and dose rate from patients
    Demir
    Demir, M.
    Gultekin, Y.
    Cavdar
    Erees, S.
    Seyis, E.
    Sayman, H.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S341 - S341
  • [40] A dose response analysis of a specific bone marrow concentrate treatment protocol for knee osteoarthritis
    Christopher J. Centeno
    Hasan Al-Sayegh
    Jamil Bashir
    Shaun Goodyear
    Michael D. Freeman
    [J]. BMC Musculoskeletal Disorders, 16
12345